Early Signs of Autism Spectrum Disorder (ASD)
Core Early Signs (12-24 months)
- Reduced social attention, including decreased eye contact and diminished response to name being called, is a key early marker of ASD in children between 12 and 24 months of age, according to the American Academy of Pediatrics 1, 2
- Limited or absent joint attention behaviors, such as inability to share focus with others about objects or events, are common in children with ASD between 12 and 24 months of age 3
- Decreased use of gestures for communication, such as pointing or waving, is a significant early sign of ASD in children between 12 and 24 months of age 4, 3
- Repetitive actions or posturing of body, arms, hands, or fingers, including hand flapping and finger flicking, are characteristic of ASD in children between 12 and 24 months of age 4, 3
- Unusual sensory interests or sensitivities, such as over- or under-responsiveness to certain sounds or textures, are common in children with ASD between 12 and 24 months of age 4, 5
Age-Related Differences
- Most children with ASD show clear signs by 18-24 months, though parents often report concerns earlier, and the average age of diagnosis in the US remains 4-5 years, according to the American Academy of Pediatrics 6, 7
Clinical Implications
- The American Academy of Pediatrics recommends screening at 18-24 months to promote earlier diagnosis, and referral for autism-specific screening and comprehensive evaluation is recommended when concerns about early signs are raised by parents or observed by healthcare professionals 1, 2, 8
- Early identification allows for timely intervention, which can significantly improve developmental outcomes in children with ASD, and the American Academy of Pediatrics emphasizes the importance of early screening and referral 1, 8
Common Pitfalls to Avoid
- Waiting for language delay as the primary indicator of ASD, when social communication differences often appear earlier, is a common pitfall, and the American Academy of Pediatrics recommends a comprehensive evaluation that includes social communication and behavioral assessments 1, 4
- Failing to recognize the variability in symptom onset and developmental trajectories is a significant pitfall, and the American Academy of Pediatrics emphasizes the importance of considering individual differences in ASD presentation 1, 5
Autism Screening and Developmental Surveillance in High‑Risk Infants
Standard Population Screening (18–24 months)
- The American Academy of Pediatrics recommends universal autism screening for all children at 18–24 months, using tools such as the Modified Checklist for Autism in Toddlers (M‑CHAT), which show optimal performance in this age window. Strong recommendation. 9, 10, 11
Limitations of Screening Before 18 months
- Screening at 14–15 months detects fewer than 1 case per 1,000 children and has a low positive predictive value of 0.25, indicating that most positive screens would be false positives. Weak evidence. 9, 10
- Because autism symptoms emerge gradually over the first 24 months, screening before 18 months yields higher false‑negative rates and reduced sensitivity. Moderate evidence. 9, 10
Elevated Recurrence Risk in Siblings
- Siblings of a child with autism have a recurrence risk of 7 %–18 %, markedly higher than the general population risk of approximately 1.7 %. Strong evidence. 11, 12
- High‑risk siblings demonstrate significantly greater deficits in social communication, lower cognitive functioning, and higher autism‑related symptom scores compared with low‑risk children. Strong evidence. 11, 12
Recommended Surveillance and Screening Schedule for High‑Risk Infants
- Children with a familial autism history should receive continuous developmental surveillance at every well‑child visit and undergo formal autism screening at both 18 months and 24 months. Strong recommendation. 11, 12
- At the 12‑month visit, clinicians should perform enhanced developmental surveillance, actively monitoring for early red‑flag signs even though formal autism screening is not yet indicated. Strong recommendation. 11, 12
Early Broadband Developmental Screening When Specific Concerns Exist
- If parents voice specific developmental concerns before 18 months, clinicians may use broadband developmental screening tools (e.g., the CSBS‑DP Infant/Toddler Checklist) to detect possible autism as early as the first birthday. Moderate evidence. 9, 13
Clinical Pitfalls to Avoid
- Do not simply reassure families without establishing a surveillance plan; the presence of a first‑degree relative with autism mandates closer monitoring. Strong recommendation. 11, 12
Autism Recurrence Risk and Surveillance in High‑Risk Siblings
Recurrence Risk Estimates
- Sibling recurrence after one affected child – Prospective cohort studies from the Baby Siblings Research Consortium report a 18 %–20 % recurrence risk for autism spectrum disorder (ASD) in the next child. Evidence level: high‑quality prospective cohort (Level B). 14
- Population‑based Danish data – Nationwide registry analyses estimate a more conservative recurrence risk of 6 %–8 % for siblings, still markedly higher than the general population baseline. Evidence level: large‑scale epidemiologic study (Level B). 15
- Two or more previously affected siblings – The risk of ASD in any subsequent pregnancy rises dramatically to 32 %–50 %. Evidence level: cohort study (Level B). 16
- Effect of proband sex – When the first affected child is female, the recurrence risk for later children is higher, reflecting a greater underlying genetic burden. Evidence level: systematic review/meta‑analysis (Level B). 17
- Male‑only sibling pairs – In families with two affected boys, the probability that the next male child will develop ASD is approximately 32 %. Evidence level: cohort analysis (Level B). 17
Developmental Surveillance and Autism‑Specific Screening
- Intensified surveillance – The American Academy of Pediatrics (AAP) recommends that all infant siblings of children with ASD receive continuous developmental monitoring at every well‑child visit, with formal autism‑specific screening at 18 months and again at 24 months. Evidence level: guideline based on multiple prospective studies (Level A). 14
- First screen at 18 months – Use of the Modified Checklist for Autism in Toddlers (M‑CHAT) is advised as the initial autism‑specific screening tool at 18 months of age. Evidence level: validated screening instrument (Level A). 18
- Second screen at 24 months – A repeat autism‑specific screen is performed at 24 months to capture later‑emerging signs. Evidence level: guideline recommendation (Level A). 15
Early Behavioral Indicators (12–24 months)
- Reduced social attention – Diminished eye contact and weaker response to the child’s name are observable between 12–18 months in high‑risk siblings. Evidence level: prospective observational cohort (Level B). 19
- Joint‑attention deficits – Failure to share focus on objects or events with caregivers is a frequent early marker. Evidence level: prospective cohort (Level B). 19
- Limited gestural communication – Decreased pointing, waving, or showing objects emerges in the first two years. Evidence level: prospective cohort (Level B). 19
- Declining social engagement – A downward trajectory of social smiles, directed vocalizations, and overall social interest is noted from 6 to 18 months. Evidence level: longitudinal cohort (Level B). 20
- Repetitive motor behaviors – Hand‑flapping, atypical finger movements, and repetitive object use appear early in many high‑risk infants. Evidence level: prospective cohort (Level B). 19
Referral Pathway and Diagnostic Stability
- Immediate specialist referral – A positive autism screen should trigger prompt referral to a developmental specialist (e.g., developmental‑pediatrician, speech‑language pathologist, psychologist) for comprehensive diagnostic evaluation. Evidence level: guideline recommendation (Level A). 14
- Concurrent early‑intervention referral – Children with a positive screen should be referred to early‑intervention services without awaiting a definitive diagnosis, to start therapy as soon as possible. Evidence level: guideline recommendation (Level A). 15
- Stability of diagnoses ≥24 months – ASD diagnoses made at 24 months or older are highly stable over time. Evidence level: longitudinal follow‑up study (Level B). 18
- Stability of early diagnoses – For diagnoses made before 24 months, stability is 85 %–93 % for autistic disorder and 47 %–62 % for unspecified pervasive developmental disorder. Evidence level: longitudinal cohort (Level B). 14
Genetic Evaluation
- Chromosomal microarray (CMA) – CMA detects pathogenic variants in approximately 40 % of children with ASD, providing a substantial yield for genetic risk clarification. Evidence level: diagnostic test performance study (Level B). 17
- Clinical exome sequencing – When CMA is negative, clinical exome sequencing adds an additional 15 %–25 % diagnostic yield. Evidence level: diagnostic cohort study (Level B). 17
All facts are derived from cited peer‑reviewed sources and reflect the current evidence base as interpreted by the American Academy of Pediatrics.
Early Identification of Autism Spectrum Disorder in 2‑Year‑Olds
Early Markers (12–24 months)
- Reduced eye contact, failure to respond to one’s name, lack of pointing to show interest, absence of conventional gestures (e.g., waving, showing), limited joint‑attention behaviors, and repetitive motor movements such as hand‑flapping are the most reliable early markers of ASD in children aged 12–24 months. 21, 22
Social‑Communication Red Flags
- Diminished or inconsistent eye contact during caregiver interactions is a common early sign of ASD. 21
- Failure to respond when the child’s name is called at 12 months is highly specific for later developmental abnormality (86 % of at‑risk infants who fail this test develop abnormalities). 21, 23
- Reduced social smiling and lower positive affect toward caregivers are frequently observed in toddlers with ASD. 21, 23
Joint‑Attention and Gesture Deficits
- Lack of spontaneous pointing to show interest (not merely to request) between 20–42 months is one of the most discriminating markers of ASD. 24
- Absence of conventional gestures such as waving goodbye or showing objects to share interest is characteristic of ASD. 24
- Fewer non‑verbal initiations of shared experiences (e.g., not bringing objects to show the caregiver) are noted in children with ASD. 21, 23
- Reduced frequency of both verbal and non‑verbal requesting behaviors is typical in this age group. 21
- Deficits in attention to voice and decreased directed vocalizations are reported in toddlers with ASD. 21
Repetitive and Sensory Behaviors
- Repetitive motor actions—including hand‑flapping, finger flicking, and unusual arm/hand posturing—are common motor stereotypies in ASD. 21, 22
- Atypical object use (e.g., spinning, lining up, or using toys in repetitive non‑functional ways) is frequently observed. 22
- Unusual sensory interests or sensitivities—over‑ or under‑responsiveness to sounds, textures, or visual stimuli—are characteristic of ASD in the second year of life. 21
Emotional Regulation and Behavioral Features
- Children with ASD show lower positive affect and higher negative affect compared with typically developing peers. 21, 23
- Difficulty controlling behavior and reduced sensitivity to social‑reward cues are noted. 21, 23
- Marked irritability and intolerance to intrusions may be present in some toddlers with ASD. 25
Developmental Trajectory Concerns
- Declining trajectories of social communication, including loss of previously acquired social engagement behaviors, can occur in ASD. 21
- Slower acquisition of new developmental milestones in language and non‑verbal cognition is reported. 25
Screening and Referral Recommendations (American Academy of Pediatrics)
- Universal autism screening is recommended at both 18 months and 24 months using validated tools such as the Modified Checklist for Autism in Toddlers (M‑CHAT). 24
- When any of the above red‑flag markers are observed, immediate referral for autism‑specific screening and a comprehensive diagnostic evaluation is indicated, with concurrent referral to early‑intervention services without waiting for a definitive diagnosis. 24, 22